Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
57,285,340
-
Total 13F shares
-
37,070,882
-
Share change
-
+1,351,185
-
Total reported value
-
$307,725,828
-
Put/Call ratio
-
68%
-
Price per share
-
$8.30
-
Number of holders
-
105
-
Value change
-
+$10,426,090
-
Number of buys
-
61
-
Number of sells
-
36
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) as of Q4 2014
As of 31 Dec 2014,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,070,882 shares.
The largest 10 holders included
NEA Management Company, LLC, Murphy Michael R, Abingworth LLP, ARDSLEY ADVISORY PARTNERS, Ameriprise Financial Inc, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Fund Advisors, NORTHPOINTE CAPITAL LLC, VANGUARD GROUP INC, and MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC.
This page lists
105
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.